Skip to content

Dolutegravir

Dolutegravir is an antiretroviral medication used to suppress viral replication in individuals living with HIV Infection. Approaches to HIV Management often include products like Tivicay and Triumeq. Two variations of this formulation are available, including film-coated tablets and standard tablets, designed to support viral health.

Triumeq

HIV Infection

600/50/300mg

Abacavir, dolutegravir and lamivudine in one tablet, used in the management of HIV infection. Three agents against three stages of the viral cycle.

From$8.69/ tabletView

Tivicay

HIV Infection

50mg

Dolutegravir 50mg film-coated tablets, used in the management of HIV infection. An integrase inhibitor that blocks the strand transfer step.

From$2.74/ tabletView

Key points

  • Blocks integrase, the enzyme HIV needs to insert its genetic material into human cells, halting viral replication.
  • Comes as film-coated or standard tablets, both intended for oral use to keep blood levels steady.
  • Antacids containing magnesium or calcium can interfere with absorption, so timing relative to those products matters.
  • Liver function and viral load are typically monitored during treatment to track how well the regimen is working.

What is Dolutegravir?

Dolutegravir is an integrase strand transfer inhibitor, a type of antiretroviral drug. By preventing the virus from inserting its genetic material into human cell DNA, the medication stops the virus from multiplying. This class of medication functions as a core component for long-term health outcomes for those requiring such treatment.

What Dolutegravir is used for

Management of HIV-1 infection is the primary purpose of this medication. By lowering the amount of virus in the body, it maintains immune system function over time. Using the medication as directed allows for consistent viral control and contributes to better clinical outcomes.

How does Dolutegravir work?

Mechanisms behind viral control involve blocking an enzyme called integrase. This enzyme is required by the virus to insert its genome into human cells. When this mechanism is blocked, the virus cannot replicate and spread to other cells, which reduces the viral load in your blood.

Dolutegravir forms

Film-coated tablets and standard tablets are the available forms for this medication. These variations are designed for oral administration and aim to ensure consistent therapeutic levels within the bloodstream.

Safety overview for Dolutegravir

What to check before using this medicine

Liver function tests and viral load monitoring are standard requirements. Complete medical history review allows for better management, particularly if liver conditions are present.

Possible reactions and tolerability

Insomnia, headache, and fatigue are sometimes reported. Weight changes or gastrointestinal symptoms can also occur. Many people tolerate the medication well.

Interactions and health factors

Anti-acid preparations containing magnesium or calcium may interfere with absorption. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading